NEW YORK (
was one of several stocks trading below $5 were poised to move on above-average volume Tuesday after its largest shareholder said it is selling its stake in the company.
, a developer of touring museum-quality exhibits, said that
Sellers Capital Master Fund
has begun a search for a single buyer of its 46% equity investment in Premier's common stock. SCF said it intends to return all capital to its investors over the next 12 to 18 months following redemption requests. SCF also said it will not sell any of Premier's shares in the open market.
Shares of Premier Exhibitions jumped by 18 cents, or 13.6%, to $1.50 in the premarket session after the company. The 50-day average daily volume for is 67,000, according to the
dropped by 50 cents, or 10.4%, to $4.30 in Monday's after-market session after the technology infrastructure solutions provider said it expects errors from previous financial statements to be corrected in "weeks not months."
On Monday, INX said it would restate financial results due to certain errors affecting the timing of recognition of revenues and costs of revenues between these periods. The 50-day average daily volume for INXI is 11,000.
Molecular Insight Pharmaceuticals
rose by 15 cents, or 8.3%, to $1.95 in the premarket session after the company said it has received a third extension of its waiver agreement with its bond holders, allowing debt restructuring discussions to progress. The 50-day average daily volume for Molecular Insight is 764,000.
-- Written by Robert Holmes in Boston
Follow Robert Holmes on
and become a fan of TheStreet.com on